Spectrum Pharmaceuticals Inc. (SPPI)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Thomas J. Riga
Employees:
160
11500 S. EASTERN AVE., SUITE 240, HENDERSON, NV, 89052
702-835-6300
-
Formally known as:
- Neotherapeutics Inc
Date | Ratio |
---|---|
2002-09-06 | 1:25 |
Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia. Anti-CD20-IFNa is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|